{"news_desk": "Business", "print_page": "3", "section_name": "Health", "subsection_name": null, "byline": {"original": "By GINA KOLATA", "person": [{"rank": 1, "role": "reported", "firstname": "Gina", "organization": "", "lastname": "KOLATA"}]}, "abstract": "Food and Drug Administration approves Amgen's cholesterol-lowering drug Repatha; drug is second in new class of extremely effective drugs known as PCSK9 inhibitors and are intended for people who cannot lower their cholesterol levels with statins and other therapies.", "type_of_material": "News", "word_count": "898", "lead_paragraph": "The new drug is made by Amgen for people with extremely high cholesterol levels and heart patients who do not get adequate results from statins and other therapies.", "pub_date": "2015-08-28T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "F.D.A. Approves Repatha, a Second Drug for Cholesterol in a Potent New Class", "print_headline": "F.D.A. Approves the Second Drug for Cholesterol in a Potent New Class"}, "snippet": "The new drug is made by Amgen for people with extremely high cholesterol levels and heart patients who do not get adequate results from statins and other therapies.", "multimedia": [{"height": 126, "url": "images/2015/08/28/science/28DRUG1/28DRUG1-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/08/28/science/28DRUG1/28DRUG1-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 400, "url": "images/2015/08/28/science/28DRUG1/28DRUG1-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2015/08/28/science/28DRUG1/28DRUG1-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/08/28/science/28DRUG1/28DRUG1-thumbStandard-v2.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/08/28/science/28DRUG1/28DRUG1-thumbStandard-v2.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/08/28/health/fda-approves-another-in-a-new-class-of-cholesterol-drugs.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Cholesterol", "name": "subject"}, {"rank": "2", "is_major": "N", "value": "Repatha (Drug)", "name": "subject"}, {"rank": "3", "is_major": "Y", "value": "Amgen Inc", "name": "organizations"}, {"rank": "4", "is_major": "Y", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "5", "is_major": "Y", "value": "Food and Drug Administration", "name": "organizations"}, {"rank": "6", "is_major": "Y", "value": "Heart", "name": "subject"}], "blog": [], "_id": "55df80f338f0d81634aff4a9", "source": "The New York Times"}